HMN
Horace Mann Educators Corporation
HMN's fundamentals are mixed: revenue grew 4.2%, while its operating margin held steady at 12%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
HMN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HMN's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HMN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
HMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $45.56 | -14% |
| Forward | 11x | $52.78 | — |
| Current | 12x | $52.78 | — |
| Fair | 13x | $57.21 | +8.4% |
| Expensive | 21x | $88.69 | +68% |
Historical ranges are pointers, not guarantees.
HMN's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
HMN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HMN's earnings to grow and its profitability to improve, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.02 | +17% |
| Q3 2026 | $4.29 | +8.6% |
| Q2 2026 | $4.28 | +27% |
| Q1 2026 | $3.98 | +44% |
| Q4 2025 | $3.90 | +57% |
| Q3 2025 | $3.95 | +57% |
| Q2 2025 | $3.38 | +72% |
| Q1 2025 | $2.76 | +76% |
| Q4 2024 | $2.48 | +128% |
HMN has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
HMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $439.2M | +0.2% |
| Q2 2026 | $443.5M | +7.7% |
| Q1 2026 | $429.3M | +3.1% |
| Q4 2025 | $434.8M | +6.3% |
| Q3 2025 | $438.5M | +6.4% |
| Q2 2025 | $411.7M | +6.1% |
| Q1 2025 | $416.4M | +7.9% |
| Q4 2024 | $409M | +1.5% |
HMN's revenue has grown year over year for 17 quarters in a row: $439M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +0.2 points |
| Q2 2026 | 11% | +2.2 points |
| Q1 2026 | 12% | +0.3 points |
| Q4 2025 | 11% | -1.3 points |
| Q3 2025 | 16% | +5.9 points |
| Q2 2025 | 8.9% | +7.7 points |
| Q1 2025 | 11% | +2.9 points |
| Q4 2024 | 12% | +0.1 points |
HMN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
HMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $112M | -26% |
| Q2 2026 | $223.7M | +70% |
| Q1 2026 | $61.3M | -56% |
| Q4 2025 | $129.9M | -33% |
| Q3 2025 | $151.2M | +5.1% |
| Q2 2025 | $131.3M | +227% |
| Q1 2025 | $140.8M | +89% |
| Q4 2024 | $193.5M | +88% |
HMN has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
HMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +200K shares |
| 1 year | -0.5% | -200K shares |
| 3 years | 0% | -- |
| 5 years | -1.9% | -800K shares |
| Available history | -1.5% | -619K shares |
HMN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | $100,000 |
| Q1 2026 | $18.3M |
| Q4 2025 | $6.9M |
| Q3 2025 | $6.8M |
| Q2 2025 | $6.9M |
| Q1 2025 | $200,000 |
| Q4 2024 | — |
HMN spent $26M buying back its own shares over the past year, up 89% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.3x | Elevated |
HMN's net debt is about 1.8 years of its operating earnings (EBITDA), down from 3.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like HMN.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
HMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 63.6 | Neutral |
HMN's weekly RSI is 63 (neutral) and its Stochastic is 64 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
HMN PE vs Financial Services Sector
| Metric | HMN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.5% below |
| PE % | 42 | 63 | 21 pts below |
HMN is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
HMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 11% above |
| 20 week MA | $50.0 | 5.6% above |
| 50 week MA | $46.9 | 12% above |
| 100 week MA | $44.7 | 18% above |
| 200 week MA | $39.3 | 34% above |
HMN has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
HMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.7 | $41.7 | -4.6% |
| 2021 | $41.7 | $38.6 | -7.5% |
| 2022 | $38.6 | $37.9 | -1.8% |
| 2023 | $37.9 | $32.7 | -14% |
| 2024 | $32.7 | $39.3 | +20% |
| 2025 | $39.3 | $46.5 | +18% |
| 2026 YTD | $46.5 | $52.8 | +14% |
HMN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.